Metagenomi Therapeutics Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 11,514 | 20,008 | 11,159 | 12,399 | 12,363 |
| Gross Profit | 11,514 | 20,008 | 11,159 | 12,399 | 12,363 |
| Operating Expenses | 33,897 | 36,871 | 40,191 | 32,595 | 34,758 |
| Operating Income | -22,383 | -16,863 | -29,032 | -20,196 | -22,395 |
| Other Income | 1,504 | 3,925 | 3,884 | 3,628 | 3,781 |
| Pre-tax Income | -20,879 | -12,938 | -25,148 | -16,568 | -18,614 |
| Income Tax | -2,106 | -2,199 | N/A | 2,726 | 1,206 |
| Net Income Continuous | -18,773 | -10,739 | -25,148 | -19,294 | -19,820 |
| Net Income | $-18,773 | $-10,739 | $-25,148 | $-19,294 | $-19,820 |
| EPS Basic Total Ops | -0.51 | -0.29 | -1.19 | -5.67 | -5.82 |
| EPS Basic Continuous Ops | -0.51 | -0.29 | -1.19 | -5.67 | -5.82 |
| EPS Diluted Total Ops | -0.51 | -0.29 | -1.19 | -5.67 | -5.82 |
| EPS Diluted Continuous Ops | -0.51 | -0.29 | -1.19 | -5.67 | -5.82 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.29 | -1.19 | N/A | N/A |
| EBITDA(a) | $-24,151 | $-17,611 | $-29,010 | $-20,703 | $-23,704 |